查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1988267

质谱市场：按产品、应用和最终用户划分－2026-2032年全球市场预测

Mass Spectrometry Market by Product, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，质谱市场价值将达到 64 亿美元，到 2026 年将成长至 68.9 亿美元，到 2032 年将达到 111.2 亿美元，复合年增长率为 8.20%。

主要市场统计数据
基准年 2025 64亿美元
预计年份：2026年 68.9亿美元
预测年份 2032 111.2亿美元
复合年增长率 (%) 8.20%

本策略性介绍概述了当前形势，即随着技术的快速发展，质谱技术在临床诊断研究和工业应用中的作用正在扩大。

质谱技术在分析精度和策略决策方面都处于关键地位，对各行各业的实验室、仪器製造商和终端用户都至关重要。随着仪器灵敏度的提高和资料处理技术的日益复杂，相关人员必须使其技术选择与营运目标、监管要求和不断变化的应用需求保持一致。本导言概述了重塑该领域的关键驱动因素，并为后续章节奠定了基础。后续章节将探讨技术转折点、政策影响、细微的细分市场差异、区域趋势、竞争格局以及建议措施。

仪器设计、资料科学和整合工作流程的快速发展如何从根本上重塑质谱的竞争格局和应用领域。

随着技术、数据和工作流程的进步，质谱分析领域正在发生变革，全面重新定义了绩效预期和价值提案。仪器层面的最新进展着重提升了解析度和采集速度，使得以往在日常环境中难以实现的分析成为可能。除了硬体改进之外，环境电离技术的进步、样品製备的简化以及模组化前端系统的出现，不仅缩短了获得结果的时间，还拓展了可进行分析的范围。这些技术进步降低了环境筛检和食品安全等应用领域的进入门槛，同时也为蛋白质体学和法医学的更精细分析提供了可能。

评估近期美国关税措施对质谱生态系统在营运、采购和供应链方面的累积影响。

政策和贸易趋势为分析仪器的采购和供应链规划带来了新的复杂性。近期政策週期中实施的关税措施影响了依赖专用质谱仪的实验室的筹资策略、零件供应和总到岸成本。为此，製造商和采购商正在重新审视其供应商多元化、库存缓衝和本地组装策略，以维持服务的连续性并保障长期的研发和测试项目。

透过整合产品应用和最终用户趋势的详细细分洞察，可以揭示客製化设备和软体策略能够提供竞争优势的领域。

对产品、应用和最终用户细分的精准理解，有助于明确质谱投资能够带来差异化价值的领域，以及针对性创新能够解锁新功能的领域。基于产品，市场可分为两大类：「仪器」和「软体」。仪器类又可细分为气相层析法联用（GC-MS）、离子层析法-质谱联用（IC-MS）、层析法质谱联用（LC-MS）、基质辅助雷射解吸/飞行时间（MALDI-TOF-MS）及四极桿质谱（Q-MS）。这种产品层面的观点凸显了清晰的发展路径。层析法联用技术仍是常规定量工作流程的主要驱动力，而MALDI-TOF和高解析度平台则能够实现快速鑑定和探索性分析。

影响实施支援和商业化路径的美洲、欧洲、中东和非洲以及亚太地区的区域趋势和战略考量。

在全球质谱领域，区域趋势影响投资重点、监管要求和伙伴关係模式。在美洲，成熟的临床和製药生态系统持续推动对经过验证的高通量平台和整合数据解决方案的需求，而强大的服务市场则支援仪器的长生命週期和分析方法的快速应用。供应商与大型终端用户之间的关係以捆绑式服务协议为特征，从而确保关键任务的顺利运作和本地化的技术支援。

竞争动态和企业策略揭示了软体服务模型和工作流程验证如何决定供应商差异化和长期采用率。

质谱领域的竞争格局呈现出老字型大小企业与新兴专业公司并存的局面，软体生态系统、服务模式和检验的应用套装程式日益成为差异化竞争的关键驱动因素。老牌仪器供应商凭藉着深厚的工程技术和全球服务网络，持续赢得受监管终端用户的信赖。同时，一些规模较小的公司则专注于模组化设计、快速创新週期以及在细分应用领域的领先地位。硬体可靠性与数据分析能力之间的相互作用，使得伙伴关係与收购成为快速弥补产品组合缺口的关键策略。

为产业领导者提供切实可行的建议，以协调采购人才和伙伴关係策略，并加速采用检验的质谱工作流程。

希望利用质谱创新技术的领导者应着重于技术、人才和伙伴关係关係的策略整合，以加速价值实现。首先，应优先投资于能够提供检验的工作流程和无缝资料整合的平台，从而缩短行动时间并加强合规性。其次，应透过有针对性的培训项目以及与学术机构和标准检测实验室的合作，拓展内部分析能力，弥合营运差距，​​并推动先进分析方法的开发。此类投资将透过减少对外部服务供应商的依赖和缩短关键检测结果的获取时间，带来显着成效。

技术和商业性见解透过高度透明的调查方法进行检验，该方法整合了与相关人员的访谈、供应商材料、监管指南和同行评审的科学文献。

本摘要的研究整合了对关键相关人员的访谈、供应商资料、监管指南和同行评审文献，旨在建立对技术和商业性趋势的平衡视角。主要资讯来源包括对临床、环境和工业检测机构的实验室主任、采购负责人和技术负责人进行的结构化访谈，以及与专注于蛋白质组学和法医学分析的研究型终端用户的对话。供应商的产品规格和白皮书用于评估仪器性能，而调查方法学论文和标准指南则用于检验有关可重复性和应用适用性的说法。

总结了整合仪器数据工作流程和稳健的供应策略如何决定质谱的长期策略价值。

先进设备、以数据为中心的工作流程以及日益增强的供应链意识的融合，正在重塑质谱部署的策略决策框架。整合高效能硬体、强大的软体、检验的工作流程和可靠的服务基础设施的机构，将能够在诊断研究和工业应用的各个领域实现价值最大化。在这个不断发展的技术格局中，将仪器层面的改进转化为营运效率和法规遵从性的能力，正成为实验室领导者的关键技能。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 质谱市场：依产品分类

  • 装置
    • 气相层析法和质谱
    • 离子层析法-质谱法
    • 液相层析质谱联用
    • 基质辅助雷射解吸/电离飞行时间质谱法
    • 四极桿质谱法
  • 软体

第九章 质谱市场：依应用领域划分

  • 临床诊断
  • 环境测试
  • 食品和饮料检查
  • 法医学
  • 蛋白质体学

第十章 质谱市场：依最终用户划分

  • 学术和研究机构
  • 环境检测实验室
  • 食品饮料业
  • 法医学研究所
  • 製药和生物技术公司

第十一章 质谱市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 质谱市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 质谱市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章 美国质谱市场

第十五章 中国质谱市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 908 Devices Inc.
  • Advion, Inc.
  • Agilent Technologies, Inc.
  • AMETEK Inc.
  • Analytik Jena AG
  • Avantor, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • DANI Instruments SpA
  • F. Hoffmann-La Roche AG
  • FLIR Systems, Inc.
  • Hiden Analytical, Inc.
  • Hitachi, Ltd.
  • JEOL Ltd.
  • Kore Technology Limited
  • LECO Corporation
  • Merck KGaA
  • MKS Instruments, Inc.
  • PerkinElmer, Inc.
  • Pfeiffer Vacuum GmbH
  • Process Insights AG
  • Rigaku Corporation
  • SCIEX AB
  • Shimadzu Corporation
  • Spectrum Chemical Mfg. Corp.
  • Thermo Fisher Scientific Inc.
  • VProteomics Company
  • Waters Corporation
Product Code: MRR-6B77D7DC7872

The Mass Spectrometry Market was valued at USD 6.40 billion in 2025 and is projected to grow to USD 6.89 billion in 2026, with a CAGR of 8.20%, reaching USD 11.12 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.40 billion
Estimated Year [2026] USD 6.89 billion
Forecast Year [2032] USD 11.12 billion
CAGR (%) 8.20%

A strategic introduction framing the expanding role of mass spectrometry across clinical diagnostics research and industrial applications amid rapid technological evolution

Mass spectrometry stands at the intersection of analytical precision and strategic decision-making for laboratories, instrument manufacturers, and end users across sectors. As instrumentation becomes more sensitive and data handling more sophisticated, stakeholders must align technology choices with operational objectives, regulatory expectations, and evolving application demands. This introduction outlines the core forces reshaping the field and frames the subsequent sections that explore technology inflections, policy impacts, segmentation nuances, regional dynamics, competitive behavior, and recommended actions.

The discipline now spans routine clinical workflows to cutting-edge proteomics and environmental surveillance, demanding versatility from platforms and clarity from decision-makers. With an accelerating pace of methodological innovation and growing demand for reproducible, high-throughput analyses, organizations must reexamine procurement criteria, laboratory design, and talent development. This introductory overview emphasizes that strategic adoption of mass spectrometry requires both technical literacy and a clear alignment to organizational priorities, from regulatory compliance to scientific differentiation. The remainder of this executive summary builds on that premise to deliver actionable insight for leaders preparing to invest in or deploy mass spectrometry capabilities.

How rapid advances in instrument design data science and integrated workflows are fundamentally reshaping the competitive and application landscape for mass spectrometry

The landscape for mass spectrometry is being transformed by a confluence of technical, data, and workflow shifts that collectively redefine performance expectations and value propositions. Recent instrument-level advances emphasize higher resolving power and faster acquisition rates, enabling analyses that were previously impractical in routine settings. Complementing hardware improvements, advances in ambient ionization, simplified sample preparation, and modular front-end systems reduce time to result while widening the range of feasible assays. These technical gains are simultaneously lowering barriers for applications such as environmental screening and food safety while enabling deeper interrogation in proteomics and forensics.

Parallel to instrumentation evolution, software and data science have emerged as pivotal differentiators. Machine learning algorithms and automated spectral interpretation accelerate throughput and reduce operator dependence, while cloud-enabled platforms facilitate collaborative analysis and remote method development. Interoperability between instrument vendors and third-party informatics providers is becoming a competitive imperative. As the ecosystem matures, value shifts from individual instruments to integrated solutions that pair robust hardware with comprehensive data workflows, regulatory-ready reporting, and user-centered interfaces. For organizations, this means procurement decisions increasingly hinge on software roadmaps, lifecycle support, and the vendor's ability to deliver validated workflows rather than on hardware metrics alone.

Assessing the cumulative operational procurement and supply chain consequences of recent United States tariff measures on the mass spectrometry ecosystem

Policy and trade dynamics have introduced new layers of complexity to procurement and supply chain planning for analytical instrumentation. Tariff measures enacted in recent policy cycles have affected sourcing strategies, component availability, and total landed costs for laboratories that rely on specialized mass spectrometry equipment. In response, manufacturers and buyers have reexamined supplier diversification, inventory buffering, and local assembly strategies to maintain continuity of service and protect long-term research and testing programs.

The cumulative effect of these trade actions has been to accelerate certain strategic behaviors among stakeholders. Instrument vendors have intensified efforts to localize key manufacturing steps or secure alternate supply channels for critical optics and electronics. Laboratories are prioritizing lifecycle planning and strengthening service contracts to mitigate the operational risk of delayed deliveries. Procurement teams are engaging earlier with technical and finance stakeholders to evaluate procurement windows and evaluate the trade-offs between faster delivery and specific configuration needs. Overall, the tariff environment has underscored the importance of supply chain resilience and prompted a more strategic approach to vendor selection and contract structuring across the sector.

Granular segmentation insights synthesizing product application and end-user dynamics to reveal where tailored instrument and software strategies create competitive advantage

A refined understanding of product, application, and end-user segmentation clarifies where investments in mass spectrometry deliver differentiated value and where targeted innovation can unlock new capabilities. Based on Product, the market is studied across Instruments and Software, and the Instruments category further differentiates across Gas Chromatography-Mass Spectrometry, Ion Chromatography Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry, and Quadrupole Mass Spectrometry. This product-level view highlights distinct development pathways: chromatographic hyphenation continues to drive routine quantitative workflows, while MALDI-TOF and high-resolution platforms enable rapid identification and discovery-oriented analyses.

Based on Application, the market is studied across Clinical Diagnostics, Environmental Testing, Food & Beverage Testing, Forensics, and Proteomics, revealing divergent performance priorities and validation requirements across use cases. Clinical diagnostics and regulated testing emphasize reproducibility, validated workflows, and perpetual compliance documentation, whereas proteomics and forensics often demand the highest sensitivity and resolution to support novel discovery or evidentiary standards. Based on End User, the market is studied across Academic & Research Institutions, Environmental Testing Labs, Food & Beverage Industry, Forensic Labs, and Pharmaceutical & Biotechnology Firms, each exhibiting unique procurement cycles, budgetary constraints, and in-house expertise profiles. When these segmentation dimensions are considered together, it becomes clear that vendors and laboratory leaders must tailor propositions to the intersection of instrument capability, application rigor, and user sophistication to achieve sustained adoption.

Regional dynamics and strategic considerations across the Americas Europe Middle East and Africa and Asia-Pacific that influence adoption support and commercialization pathways

Regional dynamics are shaping investment priorities, regulatory requirements, and partnership models across the global mass spectrometry landscape. In the Americas, well-established clinical and pharmaceutical ecosystems continue to drive demand for validated, high-throughput platforms and integrated data solutions, while a strong service market supports long instrument lifecycles and rapid method deployment. Relationships between vendors and large-scale end users are characterized by bundled service agreements and localized technical support infrastructure that enable mission-critical operations.

In Europe, Middle East & Africa, heterogeneity across national regulatory regimes and funding environments creates a mosaic of adoption patterns, with some markets prioritizing cutting-edge research instrumentation and others emphasizing cost-effective surveillance and environmental monitoring. Strategic collaborations with centralized reference laboratories and public health agencies are common, enabling technology diffusion and shared method development. In Asia-Pacific, investment is skewed toward capacity expansion and rapid scaling, driven by both private sector R&D and public-sector surveillance initiatives. High-volume manufacturing hubs in the region also influence supply chain considerations and encourage regional OEM partnerships. Across regions, localization of service, regulatory alignment, and the ability to support cross-border workflows are decisive factors in long-term vendor success.

Competitive dynamics and company strategies that reveal how software service models and workflow validation determine vendor differentiation and long-term adoption

Competitive behavior in the mass spectrometry space reflects a mix of legacy incumbents and emergent specialists, with differentiation increasingly driven by software ecosystems, service models, and validated application packages. Established instrument suppliers continue to leverage deep engineering expertise and global service networks to maintain trust among regulated end users, while leaner companies focus on modular designs, rapid innovation cycles, and niche application dominance. The interplay between hardware reliability and data analytics capabilities has elevated partnerships and acquisitions as common strategies to fill portfolio gaps quickly.

From a commercialization perspective, companies that embed workflow automation, regulatory-ready reporting, and open data standards into their product suites gain a meaningful advantage in heavily regulated segments. Meanwhile, providers targeting discovery and high-resolution applications concentrate on extending dynamic range and improving throughput without sacrificing spectral fidelity. Across the vendor landscape, the capacity to provide reproducible methods, comprehensive training, and responsive after-sales support remains a critical differentiator that influences procurement decisions and long-term client retention.

Actionable recommendations for industry leaders to align procurement talent and partnership strategies and accelerate adoption of validated mass spectrometry workflows

Leaders seeking to capitalize on mass spectrometry innovation should focus on strategic alignment across technology, talent, and partnerships to accelerate value realization. First, prioritize investments in platforms that offer validated workflows and seamless data integration to reduce time to usable results and to strengthen regulatory readiness. Second, expand in-house analytical capabilities through targeted training programs and partnerships with academic or reference laboratories to bridge operational gaps and enable advanced method development. Such investments pay dividends by reducing dependency on external service providers and improving time-to-insight for critical assays.

Third, reassess procurement approaches to emphasize supplier resilience and lifecycle support; secure service-level commitments that include parts, calibration, and software updates to safeguard continuity. Fourth, consider collaboration models that pair instrument providers with third-party informatics specialists to accelerate adoption of AI-driven interpretation and automated reporting. Finally, align commercial and R&D roadmaps to prioritize applications with clear clinical or regulatory value, ensuring that new method introductions are accompanied by validation packages and user training to drive uptake in regulated environments.

Transparent research methodology blending stakeholder interviews vendor documentation regulatory guidance and peer-reviewed science to validate technical and commercial insights

The research underpinning this summary synthesizes primary stakeholder interviews, instrument vendor documentation, regulatory guidance, and peer-reviewed literature to create a balanced view of technical and commercial trends. Primary inputs included structured interviews with laboratory directors, procurement officers, and technology leaders across clinical, environmental, and industrial testing sites, supplemented by conversations with research-focused end users specializing in proteomics and forensic analysis. Vendor product specifications and white papers were used to evaluate instrument capabilities, while methodological papers and standards guidance helped validate claims around reproducibility and application fit.

Analytical rigor was maintained through cross-validation of qualitative inputs with publicly available regulatory frameworks and independent scientific literature. Emphasis was placed on identifying repeatable patterns across interviews and documented evidence rather than relying on single-source claims. The resulting synthesis prioritizes actionable insights and preserves methodological transparency to support informed decision-making by executives, scientists, and procurement professionals.

Concluding synthesis on how integrated instrumentation data workflows and resilient supply strategies determine the long-term strategic value of mass spectrometry

The convergence of advanced instrumentation, data-centric workflows, and heightened supply chain awareness is reshaping the strategic calculus for mass spectrometry adoption. Organizations that integrate high-performance hardware with robust software, validated workflows, and dependable service infrastructure will be best positioned to extract value across diagnostics research and industrial applications. As the technology landscape evolves, the ability to translate instrument-level improvements into operational efficiencies and regulatory-compliant results becomes the defining competency for laboratory leaders.

Looking ahead, success will favor those who adopt a systems view-aligning procurement, training, and data strategies to realize the full benefits of next-generation mass spectrometry. By prioritizing interoperability, reproducibility, and supplier resilience, institutions can navigate policy headwinds and technological disruption while unlocking new scientific and commercial opportunities that enhance both short-term performance and long-term strategic positioning.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Mass Spectrometry Market, by Product

  • 8.1. Instruments
    • 8.1.1. Gas Chromatography-Mass Spectrometry
    • 8.1.2. Ion Chromatography Mass Spectrometry
    • 8.1.3. Liquid Chromatography-Mass Spectrometry
    • 8.1.4. Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry
    • 8.1.5. Quadrupole Mass Spectrometry
  • 8.2. Software

9. Mass Spectrometry Market, by Application

  • 9.1. Clinical Diagnostics
  • 9.2. Environmental Testing
  • 9.3. Food & Beverage Testing
  • 9.4. Forensics
  • 9.5. Proteomics

10. Mass Spectrometry Market, by End User

  • 10.1. Academic & Research Institutions
  • 10.2. Environmental Testing Labs
  • 10.3. Food & Beverage Industry
  • 10.4. Forensic Labs
  • 10.5. Pharmaceutical & Biotechnology Firms

11. Mass Spectrometry Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Mass Spectrometry Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Mass Spectrometry Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Mass Spectrometry Market

15. China Mass Spectrometry Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. 908 Devices Inc.
  • 16.6. Advion, Inc.
  • 16.7. Agilent Technologies, Inc.
  • 16.8. AMETEK Inc.
  • 16.9. Analytik Jena AG
  • 16.10. Avantor, Inc.
  • 16.11. Bruker Corporation
  • 16.12. Danaher Corporation
  • 16.13. DANI Instruments S.p.A.
  • 16.14. F. Hoffmann-La Roche AG
  • 16.15. FLIR Systems, Inc.
  • 16.16. Hiden Analytical, Inc.
  • 16.17. Hitachi, Ltd.
  • 16.18. JEOL Ltd.
  • 16.19. Kore Technology Limited
  • 16.20. LECO Corporation
  • 16.21. Merck KGaA
  • 16.22. MKS Instruments, Inc.
  • 16.23. PerkinElmer, Inc.
  • 16.24. Pfeiffer Vacuum GmbH
  • 16.25. Process Insights AG
  • 16.26. Rigaku Corporation
  • 16.27. SCIEX AB
  • 16.28. Shimadzu Corporation
  • 16.29. Spectrum Chemical Mfg. Corp.
  • 16.30. Thermo Fisher Scientific Inc.
  • 16.31. VProteomics Company
  • 16.32. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MASS SPECTROMETRY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MASS SPECTROMETRY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ION CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ION CHROMATOGRAPHY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ION CHROMATOGRAPHY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY QUADRUPOLE MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY QUADRUPOLE MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY QUADRUPOLE MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE INDUSTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE INDUSTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE INDUSTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS MASS SPECTROMETRY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA MASS SPECTROMETRY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. GCC MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GCC MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 106. GCC MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 107. GCC MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. GCC MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. G7 MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. G7 MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 121. G7 MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 122. G7 MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. G7 MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NATO MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. NATO MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 126. NATO MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 127. NATO MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. NATO MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)